Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

20071,723 citationsJournal Articlebronze Open Access

Authors

Leslie W. Miller · General Mills (United States)

Francis D. Pagani · University of Michigan–Ann Arbor

Stuart D. Russell · Johns Hopkins Hospital

Ranjit John · University of Minnesota System

Andrew Boyle · University of Minnesota System

Keith D. Aaronson · University of Michigan–Ann Arbor

John V. Conte

Abstract

A continuous-flow left ventricular assist device can provide effective hemodynamic support for a period of at least 6 months in patients awaiting heart transplantation, with improved functional status and quality of life. (ClinicalTrials.gov number, NCT00121472 [ClinicalTrials.gov].).

Topics & Keywords

Mechanical Circulatory Support Devices Cardiac Structural Anomalies and Repair Cardiac Arrest and Resuscitation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 357, Issue 9, pp. 885-896

DOI: 10.1056/nejmoa067758

Field-Weighted Citation Impact: 77.18